Beacept 5 mg Tablets (Donepezil Hydrochloride Monohydrate)

Adult dose

Administer 5 mg of Donepezil Hydrochloride once daily before bedtime. For 4 to 6 weeks, administer the 5 mg dose and evaluate clinical response before increasing to 10 mg. Underweight elderly women should not exceed 5 mg per day.

Child dose

There is no experience of use in pediatric patients.

This medication uses Donepezil Hydrochloride Monohydrate as its main ingredient to treat symptoms of Alzheimer's dementia. First, this medication should not be used by certain patients. For example, patients who are allergic to this medication or its components, women who are pregnant or may become pregnant, and women who are breastfeeding should not take this medication. Additionally, patients with heart disease, a history of peptic ulcers, asthma or chronic obstructive pulmonary disease, and those with extrapyramidal disorders such as Parkinson's disease should use this medication with caution. This medication can slow heart rate or induce arrhythmias, and could increase stomach acid secretion, potentially worsening symptoms of peptic ulcers. Severe side effects such as fainting, heart problems, gastrointestinal bleeding, liver function abnormalities, seizures, movement disorders, severe muscle issues, shortness of breath, acute pancreatitis, acute renal failure, and sudden death may occur while taking this medication, thus if any of these symptoms appear, immediate consultation with a physician is required. Additionally, various side effects can occur, frequently reported symptoms include nausea, vomiting, diarrhea, dizziness, insomnia, appetite loss, headaches, and fatigue. Furthermore, symptoms such as hallucinations, anxiety, aggressive behavior, irregular heartbeats, skin rashes have also been reported, and any unusual symptoms should be communicated to medical personnel. This medication is not approved for use in other forms of dementia or memory disorders other than Alzheimer's dementia, and treatment should be conducted under the supervision of an experienced physician. The therapeutic effect should be regularly evaluated, and discontinuation should be considered if necessary. Patients with heart disease or electrolyte imbalances may be at risk for arrhythmias while taking this medication and may require electrocardiogram monitoring. Patients with a history of peptic ulcers or those taking non-steroidal anti-inflammatory drugs should monitor for gastrointestinal symptoms. This medication may affect driving ability or machine operation, so caution is advised during initial use or upon dosage changes. Moreover, this medication can interact with multiple drugs, so if other medications are being taken, it must be disclosed to a physician or pharmacist. Particular caution is advised when used concurrently with drugs that affect CYP3A4 and CYP2D6 enzymes, drugs that impact cardiac conduction, anticholinergic drugs, cholinergic drugs, etc. Women who are pregnant or breastfeeding should preferably avoid this medication, and if absolutely necessary, consultation with a healthcare professional should be sought before discontinuing breastfeeding. Safety in pediatric patients has not been established, and this medication should not be used in children. This medication may affect muscle enzyme and liver function test results, necessitating regular testing. In cases of overdose, severe vomiting, bradycardia, hypotension, respiratory depression, and convulsions may occur, requiring immediate medical treatment. Atropine may be used as an antidote. Lastly, this medication should be kept out of reach of children and transferring it to another container can lead to quality degradation or accidents.

Serious side effects

Fainting, bradycardia, heart block, QT interval prolongation, myocardial infarction, heart failure, peptic ulcer, perforated duodenal perforation, gastrointestinal bleeding, hepatitis, liver dysfunction, jaundice, cerebral seizures (epilepsy, convulsions, etc.), cerebral hemorrhage, cerebrovascular disorders, extrapyramidal disorders (motor function disorders, ataxia, movement disorders, dystonia, tremors, involuntary movements, gait disorders, abnormal posture, speech disorders), neuroleptic malignant syndrome (stupor, extreme muscle)

Mild side effects

• Nausea
• vomiting
• diarrhea
• appetite loss
• headaches
• fatigue
• dizziness
• insomnia
• hallucinations
• excitement

This medication should be stored in a tightly sealed container to prevent exposure to air and moisture, ideally at room temperature between 1 degree and 30 degrees Celsius. This storage method will help maintain the efficacy of the drug and prevent deterioration.

Appearance

White round film-coated tablets

Package unit

30 tablets/bottle, 60 tablets/bottle